Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
4,190,296
-
Shares change
-
-426,006
-
Total reported value, excl. options
-
$613,262,596
-
Value change
-
-$62,820,801
-
Put/Call ratio
-
2%
-
Number of buys
-
71
-
Number of sells
-
-119
-
Price
-
$146.35
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2023
269 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q3 2023.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,190,296 shares
.
Largest 10 shareholders include MORGAN STANLEY (647,127 shares), WELLS FARGO & COMPANY/MN (447,346 shares), BANK OF AMERICA CORP /DE/ (322,219 shares), UBS Group AG (268,027 shares), Royal Bank of Canada (221,881 shares), LPL Financial LLC (183,651 shares), Raymond James Financial Services Advisors, Inc. (171,851 shares), RAYMOND JAMES & ASSOCIATES (125,573 shares), Berger Financial Group, Inc (113,978 shares), and OSAIC HOLDINGS, INC. (99,669 shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.